M. Vangeenhuizen et B. Vanderknaap, RESEARCH-AND-DEVELOPMENT AND REGIONAL NETWORKS DYNAMICS IN DUTCH PHARMACEUTICAL-INDUSTRY, Tijdschrift voor economische en sociale geografie, 88(4), 1997, pp. 307-320
National conditions, particularly regulation, have been an important f
actor in the competitiveness of the Dutch pharmaceutical industry in t
he past decades. Regulation had no uniform impact on the sector, as wi
tnessed by a loss of strength in the innovative segment and a gain in
strength in the segment producing generic drugs. New product technolog
y is the major basis for competition in the innovative segment. This k
nowledge is highly specialized and often protected against a free flow
. Consequently, regional networking between companies can only be rele
vant for related companies within the same corporation. Since the late
1980s, there has been a trend for out-sourcing-of R&D to universities
, associated with different needs in the various stages of R&D. In som
e respects, there is a poor match between demand and supply of knowled
ge. Both at the national and regional level attempts are now being mad
e in order to improve the economic use of knowledge.